Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer.
A 67-year-old man underwent total resection of the left lung because of adenocarcinoma, with no evidence of extra-thoracic spread of the cancer. On follow-up, metastatic bone disease was documented and chemotherapy (CMT) which included cisplatin, docetaxel, vinorelbine, and topotecan was administered. Six months after completion of CMT, a rise in total serum protein was noted. Bone marrow biopsy revealed the diagnosis of an IgG lambda myeloma. We report a case of a man with adenocarcinoma of the lung who presented multiple myeloma after completion of chemotherapy.
Marinopoulos
Spyridon
S
Department of Respiratory and Critical Care Medicine (KAA), Sotiria Chest Hospital, 152 Mesogion Avenue, Athens, 11527, Greece. spyro@hol.gr
Skorda
Lamprini
L
Karatapanis
Stylianos
S
Rasidakis
Antonis
A
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology*; D002945:Cisplatin / Q000008:administration & dosage; D000077143:Docetaxel; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D009101:Multiple Myeloma / Q000473:pathology*; D016609:Neoplasms, Second Primary / Q000473:pathology*; D043823:Taxoids / Q000008:administration & dosage; D019772:Topotecan / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
D043823:Taxoids; D000077143:Docetaxel; D014747:Vinblastine; D019772:Topotecan; D002945:Cisplatin; D000077235:Vinorelbine